Global Intracranial Hematoma Drug Market - Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Upcoming Report
  • Aug 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Intracranial Hematoma Drug Market By Types (Epidural Hematoma, Subdural Hematoma, Subarachnoid Hemorrhage, Intracerebral Hemorrhage), Mechanism of Action (Osmotic Diuretics, Anticoagulants, Steroids Antiepileptic and Others), Drugs Type (Mannitol, Warfarin, Prednisone and Phenytoin and Others), Diagnosis (CT Scan, MRI Scan and Angiogram), Treatment (Medications, Surgical Drainage, Craniotomy), Route of Administration (Oral, Intravenous and Others), Distribution Channel (Direct, Online Pharmacy, Retailers and Others), End- Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Market Analysis: Global Intracranial Hematoma Drug Market

Global intracranial hematoma drug market is expected to grow at a substantial CAGR of 6.4% in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the rising cases of trauma, accidents, age related brain disorders, cancer among others, high prevalence of population suffering from hypertension and development in the healthcare expenditure and the government support for the research & development for new and better treatment have fueled the market growth.

Market Definition: Global Intracranial Hematoma Drug Market

Intracranial hematoma is a condition which is characterized by the deposition of blood within the skull caused by bursting of blood vessel in the brain from any type of accident or trauma. The collection of the blood within the brain tissue or underneath the skull causes pressure on the brain tissues which damages the tissues leading to symptoms such as increasing headache, vomiting, drowsiness and progressive loss of consciousness, dizziness, confusion, unequal pupil size and slurred speech.

Market Drivers:

  • Rising cases of trauma, accidents, age related brain disorders, cancer among others may act as a market driver
  • Change in lifestyles such as smoking and alcohol consumption has increased the risk for Intracranial hematoma which acts as a market driver
  • Increased research and development initiatives and expenditure, is also expected to drive the market growth

Market Restraints:

  • Stringent regulations and approval procedure by the authorities for the treatment, is expected to act as a restraint to the market growth
  • Lack of awareness amongst people about optimal diagnosis and treatment of intracranial hematoma restricts the growth of this market
  • Associated side effects of the drugs are expected to impede the market growth
  •  Invasive nature of most intra-cranial pressure monitors which can hinder the market growth

Segmentation: Global Intracranial Hematoma Drug Market

By Types

  • Epidural Hematoma
  • Subdural Hematoma
  • Subarachnoid Hemorrhage
  • Intracerebral Hemorrhage

By Mechanism of Action

  • Osmotic Diuretics
  • Anticoagulants
  • Steroids
  • Antiepileptic
  • Others

By Drugs Type

  • Mannitol
  • Warfarin
  • Prednisone
  • Phenytoin
  • Others

By Diagnosis

  • CT Scan
  • MRI Scan
  • Angiogram

By Treatment

  • Medications
  • Surgical Drainage
  • Craniotomy

By Route of Administration

  • Oral
  • Intravenous
  • Others

By Distribution Channel

  • Direct
  • Online Pharmacy
  • Retailers

  • Others

By End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia Pacific

  • South America

    • Brazil
    • Rest of South America

  • Middle East & Africa

    • South Africa
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In June 2019, Zebra Medical Vision, Inc received FDA 510(k) clearance for HealthPNX an AI alert for Intracranial Hemorrhage and pneumothorax (PNX). This AI software automatically detects patient’s internal brain bleeds based on standard, non-contrast head CTs. The usage of this software can assist  in providing early detection in people suffering from high risk of severe brain bleeding events

  • In November 2018, MaxQ AI, Ltd received 510(k) clearance from FDA for Accipio Ix intracranial hemorrhage (ICH) detection software designed to detect non-contrast head CT images. The approval of this software will help in the early detection of the hematoma

Competitive Analysis:

Global intracranial hematoma drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of intracranial hematoma drug market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

The key market players in the global intracranial hematoma drug market are Pfizer Inc, Mylan N.V, Sun Pharmaceutical Industries Ltd, Johnson & Johnson Services, Inc, Medtronic, Spiegelberg GmbH & Co. KG, InfraScan, Inc, Integra LifeSciences Corporation, Arbor Pharmaceuticals, LLC, PDS Biotechnology, Orexo AB, Purdue Pharma L.P, Pharmaxis Ltd, Teva Pharmaceutical Industries Ltd., Novo Nordisk A/S, Idorsia Pharmaceuticals Ltd, AstraZeneca, Baxter, Penumbra, Inc, and others.

Research Methodology: Global Intracranial Hematoma Drug Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents:

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technical Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report:

  • Current and future of global intracranial hematoma drug market outlook in the developed and emerging markets.
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
  • The latest developments, market shares, and strategies that are employed by the major market players.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions